Skip to main content
SpringerLink
Log in

Treat Clostridium difficile infection based on its severity and number of previous episodes

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

References

  1. van Nispen tot Pannerden CMF, Verbon A, Kuipers EJ. Recurrent Clostridium difficile infection: what are the treatment options? Drugs 2011; 71(7): 853–68

    Article  PubMed  Google Scholar 

  2. Bauer M, Kuiper E, van Dissel J, et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDAD). Clin Microbiol Infect 2009 Dec; 15(12): 1067–79

    Article  PubMed  CAS  Google Scholar 

  3. Cohen S, Gerding D, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010 May; 31(5): 431–55

    Article  PubMed  Google Scholar 

  4. McFarland L, Surawicz C, Rubin M, et al. Recurrent Clostridium difficile disease: epidemiology and clinical characteristics. Infect Control Hosp Epidemiol 1999 Jan; 20(1): 43–50

    Article  PubMed  CAS  Google Scholar 

  5. McFarland L, Elmer G, Surawicz C. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 2002 Jul; 97(7): 1769–75

    Article  PubMed  CAS  Google Scholar 

  6. Zar F, Bakkanagari S, Moorthi K, et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007 Aug; 45(3): 302–7

    Article  PubMed  CAS  Google Scholar 

  7. Kuipers E, Surawicz C. Clostridium difficile infection. Lancet 2008 May; 371(9623): 1486–8

    Article  PubMed  Google Scholar 

  8. Nelson R. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. Cochrane Database Syst Rev 2007 Jul; (3): CD004610

  9. Louie T, Miller M, Mullane K, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 2011 Feb; 364(5): 422–31

    Article  PubMed  CAS  Google Scholar 

  10. Johnson S, Crook DW, Cornely OA, et al. Randomized clinical trial (RCT) in Clostridium difficile infection (CDI) confirms superiority of fidaxomicin over vancomycin [abstract no. 711c]. Digestive Disease Week; 2010 May 1–6; New Orleans (LA)

  11. Cornely O, Miller M, Louie T, et al. Randomized controlled trial (RCT) of fidaxomicin (FDX) versus vancomycin (VAN) in treatment of recurrent Clostridium difficile infection (CDI) [abstract]. 50th Interscience Conference on Antimicrobial Agents & Chemotherapy Medical Conference; 2010 Sep 12–15; Boston (MA)

  12. Wenisch C, Parschalk B, Hasenhündl M, et al. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis 1996 May; 22(5): 813–8

    Article  PubMed  CAS  Google Scholar 

  13. McFarland L, Surawicz C, Greenberg R, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1994 Jun; 271(24): 1913–8

    Article  PubMed  CAS  Google Scholar 

  14. Surawicz C, MacFarland L, Greenberg R, et al. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 2000 Oct; 31(4): 1012–7

    Article  PubMed  CAS  Google Scholar 

  15. Lowy I, Molrine D, Leav B, et al. Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med 2010 Jan; 362(3): 197–205

    Article  PubMed  CAS  Google Scholar 

  16. O’Horo J, Safdar N. The role of immunoglobulin for the treatment of Clostridium difficile infection: a systematic review. Int J Infect Dis 2009 Nov; 13: 663–7

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Treat Clostridium difficile infection based on its severity and number of previous episodes. Drugs Ther Perspect 28, 10–13 (2012). https://doi.org/10.2165/11606180-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11606180-000000000-00000

Search

Navigation